DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Parsons-Rich D, Hua F, Li G, Kantaridis C, Pittman DD, Arkin S.
Phase 1 dose-escalating study to evaluate the safety, pharmacokinetics, and pharmacodynamics of a recombinant factor Xa variant (FXaI16L ).
J Thromb Haemost 2017;
15 (05) 931-937
We do not assume any responsibility for the contents of the web pages of other providers.